[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is U  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Usman A, Haase A, Merkert S, Göhring G, Hansmann G, Gall H, Schermuly R, Martin U, Olmer R. Generation of pulmonary arterial hypertension patient-specific induced pluripotent stem cell lines from three unrelated patients with a heterozygous missense mutation in exon 12, a heterozygous in-frame deletion in exon 3 and a missense mutation in exon 1. Stem Cell Res. 2021;55:102488.
Uslu M, Albayrak E, Kocabas F. Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content. Int Immunopharmacol. 2022;110:109035.
Ushio-Fukai M, Rehman J. Redox and Metabolic Regulation of Stem/Progenitor Cells and Their Niche. Antioxid Redox Signal. 2014.
H Ushay M. Acute Respiratory Failure in Pediatric Patients After Hematopoietic Stem Cell Transplantation-Understanding More by Working Together. Crit Care Med. 2018;46(10):1711-1713.
Usha L, Dewdney SB, Buckingham LE. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome. JAMA. 2016;316(1):93-94.
Usart M, Hansen N, Stetka J, Fonseca TAlmeida, Guy A, Kimmerlin Q, Rai S, Hao-Shen H, Roux J, Dirnhofer S, et al. The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood Adv. 2024.
Usacheva M, Swaminathan SKumar, Kirtane ARajeev, Panyam J. Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles. Mol Pharm. 2014.
Uryash A, Bassuk J, Kurlansky P, Altamirano F, Lopez JR, Adams JA. Non-Invasive Technology That Improves Cardiac Function after Experimental Myocardial Infarction: Whole Body Periodic Acceleration (pGz). PLoS One. 2015;10(3):e0121069.
Urvalek AM, Gudas LJ. Retinoic Acid and Histone Deacetylases Regulate Epigenetic Changes in Embryonic Stem Cells. J Biol Chem. 2014.
Urtasun N, Vidal-Pla A, Pérez-Torras S, Mazo A. Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors. BMC Cancer. 2015;15(1):223.
Urt A, Oliveira RJuliano, Hermeto LCorrea, Pesarini JRenato, de David N, Cantero Wde Barros, Falcão G, Marks G, Antoniolli-Silva AConceiçã. Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model. Genet Mol Biol. 2016.
Ursu SG, Maples S, Williams KJ, Patrus G, Samhouri Y, Fazal S, Mewawalla P, Sadashiv S. The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning. J Hematol. 2023;12(5):201-207.
Urso SJ, Sathaseevan A, W Derry B, Lamitina T. Regulation of the hypertonic stress response by the 3' mRNA cleavage and polyadenylation complex. Genetics. 2023.
Urrutia M, Fernández S, González M, Vilches R, Rojas P, Vásquez M, Kurte M, Vega-Letter AMaría, Carrión F, Figueroa F, et al. Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels. PLoS One. 2016;11(9):e0163735.
Urrutia DN, Caviedes P, Mardones R, Minguell JJ, Vega-Letter AMaría, Jofre CM. Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: An approach for their use in neural regeneration therapies. PLoS One. 2019;14(3):e0213032.
Urmann E, Stamm P, Wisskirchen J. [Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)]. Dtsch Med Wochenschr. 2023;148(4):170-174.
Urmann C, Oberbauer E, Couillard-Després S, Aigner L, Riepl H. Neurodifferentiating Potential of 8-Prenylnaringenin and Related Compounds in Neural Precursor Cells and Correlation with Estrogen-Like Activity. Planta Med. 2015.
Urkasemsin G, Rungarunlert S, Ferreira JN. Bioprinting Strategies for Secretory Epithelial Organoids. Methods Mol Biol. 2020;2140:243-249.
Uribe-Lewis S, Stark R, Carroll T, Dunning MJ, Bachman M, Ito Y, Stojic L, Halim S, Vowler SL, Lynch AG, et al. 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer. Genome Biol. 2015;16(1):69.
Uria-Oficialdegui ML, Navarro S, Murillo-Sanjuán L, Rodriguez-Vigil C, Benitez-Carbante MI, Blazquez-Goñi C, Salinas JA, Diaz-de-Heredia C. Dyskeratosis congenita: natural history of the disease through the study of a cohort of patients diagnosed in childhood. Front Pediatr. 2023;11:1182476.
Uri A, Lühder F, Kerkau T, Beyersdorf N. During acute Graft versus Host Disease CD28 deletion in donor CD8 , but not CD4 , T cells maintains anti-leukemia responses in mice. Eur J Immunol. 2018.
Ureshino H, Shindo T, Sano H, Kubota Y, Ando T, Kidoguchi K, Kusaba K, Itamura H, Kojima H, Kusunoki Y, et al. Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2019.
Ureshino H, Kamachi K, Kimura S. Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma. Clin Lymphoma Myeloma Leuk. 2019.
Urenda J-P, Del Dosso A, Birtele M, Quadrato G. Present and Future Modeling of Human Psychiatric Connectopathies With Brain Organoids. Biol Psychiatry. 2022.
Ureña-Bailén G, Block M, Grandi T, Aivazidou F, Quednau J, Krenz D, Daniel-Moreno A, Lamsfus-Calle A, Epting T, Handgretinger R, et al. Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies. CRISPR J. 2023.